37 results
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
(LTBI) Pathophysiology ... • HIV: 2/3 pulmonary ... Treatment: Active ... Initiating Treatment ... Diagnosis #Management #Treatment
Asthma Medications and Mechanism of Action

#Asthma #Medications #Drugs #Pulmonary #Pharmacology #Management #Treatment
Medications #Drugs #Pulmonary ... #Pharmacology # ... Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
(LTBI) Pathophysiology ... • HIV: 2/3 pulmonary ... Treatment: Active ... Initiating Treatment ... Diagnosis #Management #Treatment
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
Doses of Drugs for Treatment ... Multidrug-Resistant Tuberculosis ... MultiDrugResistant #Tuberculosis ... MDRTB #management #Treatment ... antimicrobials #pharmacology
Initial treatment of renal bone disease and cinacalcet for secondary hyperparathyroidism
Phosphate binders reduce hyperphosphataemia and hyperparathyroidism.
Initial treatment ... the first-line treatments ... #Pharmacology #Pathophysiology
â–º
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
Aspergillosis Treatment ... • Invasive pulmonary ... Aspergillosis #Treatment ... #management #pharmacology
Pott's Disease in Tuberculosis - Diagnosis and Management Summary
Epidemiology:
 - Typically from TB endemic areas
 -
Pott's Disease in Tuberculosis ... symptoms of active pulmonary ... decreased reflexes Pathophysiology ... Mycobacterium tuberculosis ... for concomitant pulmonary
Adjuvant therapies in critical care: steroids to treat infectious diseases
 - Severe Community Acquired Pneumonia
meningitis - Tuberculous ... meningitis - Tuberculous ... InfectiousDiseases #Infections #Pharmacology ... #Management #Treatment
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
management in Pulmonary ... #prescribing #Pulmonary ... Management #Algorithm #treatment ... #pharmacology
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Microbiologically Confirmed Pulmonary ... Tuberculosis - ... Guidelines #Tuberculosis ... #medications #pharmacology ... IDSA #Guidelines #Treatment